[TNXP] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 1.34%
YoY- 3.47%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 3,989 9,739 0 0 0 0 0 -
PBT -27,975 -28,981 -18,528 -11,990 -7,838 -5,479 -5,786 30.02%
Tax -1,216 -610 0 0 -5 0 -16 105.74%
NP -27,975 -28,981 -18,528 -11,990 -7,838 -5,479 -5,786 30.02%
Tax Rate - - - - - - - -
Total Cost 31,964 38,720 18,528 11,990 7,838 5,479 5,786 32.94%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -701.30 -291.31 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -58.40 -135.52 -319.96 -603.27 0.00 0.00 0.00 -
EPS Diluted -58.40 -135.52 -319.96 -603.27 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.